View More View Less
  • 1 Beijing Institute of Biotechnology, Beijing 100071, People's Republic of China
Restricted access

Abstract

The proportion of pathogenic microorganisms in the microbial world is relatively small, while their threat to human health, economic development and social stability is severe. The quantity and variation of Science Citation Index (SCI) literature related to pathogenic microorganisms may reflect the level of relevant research and the degree of attention. Here we compared trends in the quantity and variety of SCI literature relating to certain important pathogenic microorganisms published by scientists from United States and China from 1996 to 2010 by searching the Science Citation Index database. The pathogenic microorganisms in this study comprise two categories of pathogens: Bacillus anthracis, Yersinia pestis, Francisella tularensis, Ebola virus, Burkholderia pseudomallei, which belong to biodefense-associated pathogens (BDAPs) and the human immunodeficiency virus (HIV), SARS coronavirus, hepatitis B virus (HBV), Mycobacterium tuberculosis, influenza virus, which belong to the commonly encountered health-threatening pathogens. Our results showed that the United States (US) published much more SCI literature on these pathogens than China. Furthermore, literature on BDAPs published by scientists from the US has increased sharply since 2002. However, the numbers of literature relating to CEHTPs from China has demonstrated a gradual increase from 1996 to 2010. Research into pathogenic microorganisms requires three balance to be achieved: investment in BDAP and CEHTP studies; basic and applied research; a faster pace of research into pathogens and fulfilling biosafety and biosecurity requirements.

  • Atlas, RM. Bioterrorism and biodefence research: changing the focus of microbiology. Nature Reviews Microbiology 2003 1 1 7074 .

  • CDC bioterrorism agents/diseases. (2010). www.bt.cdc.gov/agent/agentlist-category.asp.

  • DeFrancesco, L. Throwing money at biodefense. Nature Biotechnology 2004 22 4 375378 .

  • Enserink, M, Kaiser, J. Has biodefense gone overboard?. Science 2005 307 5714 13961398 .

  • Fauci, AS. Emerging and re-emerging infectious diseases: Influenza as a prototype of the host-pathogen balancing act. Cell 2006 124 4 665670 .

  • Fauci, AS. Twenty-five years of HIV/AIDS. Science 2006 313 5786 409 .

  • Franco, C, Sell, TK. Federal agency biodefense funding, FY2011-FY2012. Biosecurity Bioterrorism 2011 9 2 117137.

  • Frischknecht, F. (2003). The history of biological warfare. Human experimentation, modern nightmares and lone madmen in the twentieth century. EMBO Rep, 4 Spec No: S47–52.

    • Search Google Scholar
    • Export Citation
  • Gottron, F. (2003). CRS report for congress: Project bioshield. www.fas.org/irp/crs/RS21507.pdf.

  • Gu, H. (2009). Medical microbiology (2nd ed.). Beijing: Peking University Medical Press.

  • Kaiser, J. Accidents spur a closer look at risks at biodefense labs. Science 2007 317 5846 18521854 .

  • Malakoff, D. U.S. biodefense boom: eight new study centers. Science 2003 301 5639 14501451 .

  • Morens, DM, Folkers, GK, Fauci, AS. The challenge of emerging and re-emerging infectious diseases. Nature 2004 430 8 242249 .

  • Impact Factor (2019): 2.867
  • Scimago Journal Rank (2019): 1.210
  • SJR Hirsch-Index (2019): 106
  • SJR Quartile Score (2019): Q1 Computer Science Apllications
  • SJR Quartile Score (2019): Q1 Library and Information Sciences
  • SJR Quartile Score (2019): Q1 Social Sciences (miscellaneous)
  • Impact Factor (2018): 2.770
  • Scimago Journal Rank (2018): 1.113
  • SJR Hirsch-Index (2018): 95
  • SJR Quartile Score (2018): Q1 Library and Information Sciences
  • SJR Quartile Score (2018): Q1 Social Sciences (miscellaneous)

Manuscript submission: http://www.editorialmanager.com/scim/